It is recognized that the issue of AMR must be addressed by concerted efforts of government agencies, health providers, drug industry, professional organizations, academe and civil society. Surveillance is a fundamental part of an effective response to AMR problem. It is needed to detect resistant microorganisms, enable correct decisions to be made about treatment options continue reading : The 2019 ARSP Annual Report is now available for download
Antibiotic resistance surveillance in the Philippines has moved into the genomic era, enabling better tracking of dangerous bacteria. Researchers at the Centre for Genomic Pathogen Surveillance (CGPS housed at the Wellcome Sanger Institute and The Big Data Institute (BDI), University of Oxford), and the Philippine Research Institute for Tropical Medicine (RITM), set up local DNA continue reading : Genomic surveillance of antibiotic resistance in the Philippines established
On the 24th of March 2020, Antimicrobial Resistance Surveillance Reference Laboratory published an original article on Salmonella at the Philippine Journal of Pathology. The study entitled, “A Fifteen-Year Report of Serotype Distribution and Antimicrobial Resistance of Salmonella in the Philippines” described the epidemiology and antimicrobial susceptibility profiles of Salmonella isolates collected in the reference laboratory continue reading : Report on serotype distribution and antimicrobial resistance of Salmonella from 2004-2018 in the Philippines published
ARSP Accreditation Services are now ONLINE! Visit https://accreditation.arsp.com.ph to create your account. Reach us on firstname.lastname@example.org or email@example.com.
The Antimicrobial Resistance Surveillance Reference Laboratory is now accepting applications for ARSP Applications from June 01-August 31, 2020 for certification with validity from July 01, 2021 to June 30, 2024. Further, please note of the following changes to the ARSP Accreditation application process effective June 11, 2020.
To know more about the data on the current status and developing trends of antimicrobial resistance of aerobic bacteria of public health importance in the Antimicrobial Resistance Surveillance Program of the Philippines, the …. Continue reading
RITM, through its Antimicrobial Resistance Surveillance Reference Laboratory (ARSRL), hosted the 31st Annual Meeting of the Department of Health (DOH) Committee on Antimicrobial Resistance Surveillance Program (ARSP) on May 21-22, 2019 at the RITM Auditorium. Laboratory Research Division Chief Dr. Amado Tandoc III welcomed all the participants, and Head of the RITM-ARSRL Dr. Sonia B. Sia followed with a presentation of a summary of the 2018 continue reading : RITM hosts 31st Annual DOH-ARSP Committee Meeting
As part of the celebration of the Antimicrobial Resistance Surveillance Program’s (ARSP) 30th Anniversary, the RITM Antimicrobial Response Surveillance Reference Laboratory (ARSRL) hosted the annual meeting and research forum with the theme “Push on and Engage in the fight against Antimicrobial Resistance: our Legacy” on May 30, 2018 at the Acacia Hotel Manila. Various officials from the Department of continue reading : ARSP celebrates 30th Anniversary
RITM, through its Antimicrobial Resistance Surveillance Program (ARSP), hosted the 1st Annual National Institute for Health Research – Global Health Research Units (NIHR-GHRU) Meeting held on May 31-June 1, 2018 at the Acacia Hotel Manila, Philippines. In coordination with the Centre for Genomic Pathogen Surveillance based at the Wellcome Trust Sanger Institute and in partnership with leading continue reading : RITM hosts the 1st National Institute for Health Research-Global Health Research Units (NIHR-GHRU) Project Meeting
“The quality of genomic sequences from RITM is at par with the sequencing done at Sanger,” says Silvia Argimon, the Lead Genomic Epidemiologist of the Centre for Genomic Pathogen Surveillance at the Wellcome Trust Sanger Institute on the laboratory capacity of RITM. The RITM-ARSP’s “See and Sequence’: Genomic Surveillance of Antimicrobial Resistant and High-risk pathogenic clones within continue reading : See and Sequence project holds Advisory Board Meeting